Maintenance therapy with oxytocin antagonists for inhibiting preterm birth after threatened preterm labour

Cochrane Database of Systematic Reviews

Volumn , Issue 1, 2009, Pages

  Papatsonis, Dimitri ^a   Flenady, Vicki ^b   Liley, Helen ^c  

^a AMPHIA HOSPITAL   (Netherlands)

^b Mater Mother's Research Centre   (Australia)

^c MATER MOTHERS HOSPITAL   (Australia)

Author keywords

Female; Humans; Obstetric labor, premature prevention control ; Pregnancy; Premature birth *prevention control ; Randomized controlled trials as topic; Receptors, oxytocin *antagonists inhibitors ; Therapeutic use ; Tocolytic agents *therapeutic use ; Vasotocin *analogs derivatives

Indexed keywords

ATOSIBAN; OXYTOCIN ANTAGONIST; PLACEBO;

BIRTH WEIGHT; CHILD DEATH; CHILDBIRTH; CLINICAL TRIAL; CONTINUOUS INFUSION; DRUG EFFICACY; DRUG SAFETY; ENTEROCOLITIS; FETUS DEATH; FOLLOW UP; HUMAN; INFANT; MAINTENANCE THERAPY; MATERNAL MORTALITY; NEWBORN INTENSIVE CARE; NEWBORN MORBIDITY; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PERINATAL DEATH; PERINATAL MORTALITY; PREMATURE LABOR; PREMATURITY; RESPIRATORY DISTRESS SYNDROME; REVIEW; SYSTEMATIC REVIEW; TOCOLYSIS; TREATMENT OUTCOME;

EID: 70249085893     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD005938.pub2     Document Type: Review

References (33)

1. Gagnon D, Martens L, Creasy G, Henke C. An economic analysis of atosiban maintenance therapy in preterm labor. American Journal of Obstetrics and Gynecology 1998;178(1 Pt 2):S181.
2. Sanchez-Ramos L, Valenzuela G, Romero R, Silver H, Koltun W, Millar L, Wang J, Creasy G, Antocin PTL 098 Study Group. A double-blind placebo-controlled trial of oxytocin receptor antagonist (antocin) maintenance therapy in patients with preterm labor. American Journal of Obstetrics and Gynecology 1997;176(1Pt 2):S30.
3. Valenzuela G, Sanchez-Ramos L, Romero R, Silver HM, Koltun WD, Millar L, et al. Maintenance treatment of pretermlabor with the oxytocin antagonist atosiban. The Atosiban PTL-098 Study Group. American Journal of Obstetrics and Gynecology 2000;182(5):1184-1190
4. Anotayanonth S, Subhedar NV, Garner P, Neilson JP, Harigopal S. Betamimetics for inhibiting preterm labour. Cochrane Database of Systematic Reviews 2004, Issue 4. [DOI: 10.1002/14651858.CD004352.pub2]
5. Berkowitz GS, Papiernik E. Epidemiology of preterm birth. Epidemiologic Reviews 1993;15(2):414-443
6. Crowley P. Prophylactic corticosteroids for preterm birth. Cochrane Database of Systematic Reviews 1996, Issue 1. [DOI: 10.1002/14651858.CD000065. pub2]
7. Crowther CA, Moore V. Magnesium maintenance therapy for preventing preterm birth after threatened preterm labour. Cochrane Database of Systematic Reviews 1998, Issue 1. [DOI: 10.1002/14651858.CD000940]
8. Crowther CA, Hiller JE, Doyle LW. Magnesium sulphate for preventing preterm birth in threatened preterm labour. Cochrane Database of Systematic Reviews 2002, Issue 4. [DOI: 10.1002/14651858.CD001060]
9. De L Costello AM, Osrin D.Micronutrient status during pregnancy and outcomes for newborn infants in developing countries. Journal of Nutrition 2003;133:1757S-1764S.
10. Deeks JJ, Altman DG, Bradburn MJ. Systematic Reviews in Health Care: Meta-analysis in Context. In: Egger M, Davey Smith G, Altman DG, editors(s) editor(s). Statistical Methods for examining heterogeneity and combining results for several studies in Meta-analysis. 2nd edition. London (UK): BMJ Publication Group, 2001.
11. Dodd JM, Crowther CA, Dare MR, Middleton P. Oral betamimetics for maintenance therapy after threatened preterm labour. Cochrane Database of Systematic Reviews 2006, Issue 1. [DOI: 10.1002/14651858.CD003927.pub2]
12. Duckitt K, Thornton S. Nitric oxide donors for the treatment of preterm labour. Cochrane Database of Systematic Reviews 2002, Issue 3. [DOI: 10.1002/14651858.CD002860]
13. Gagnon D, Martens L, Creasy G, Henke C. An economic analysis of atosiban maintenance therapy in preterm labor. American Journal of Obstetrics and Gynecology 1998;178(1 Pt 2):S181.
14. Gaunekar NN, Crowther CA. Maintenance therapy with calcium channel blockers for preventing preterm birth after threatened preterm labour. Cochrane Database of Systematic Reviews 2004, Issue 3. [DOI: 10.1002/14651858.CD004071. pub2]
15. Gyetvai K, Hannah M, Hodnett E, Ohlsson A. Tocolysis for preterm labor: a systematic review. Obstetrics& Gynecology 1999;94(5):869-877
16. Hack M, Fanaroff AA. Outcomes of children of extremely low birthweight and gestational age in the 1990's. Early Human Development 1999;53(3):193-218.
17. Higgins J, Thompson S. Quantifying heterogeneity inmeta-analysis. Statistics in Medicine 2002;21:1559-1574
18. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions, Version 5.0.0 [updated February 2008]. The Cochrane Collaboration. Available from www.cochrane-handbook.org. The Cochrane Collaboration. Available from www.cochrane-handbook.org, 2008.
19. King JF, Grant A, Keirse MJNC, Chalmers I. Beta-mimetics in preterm labour: an overview of the randomized controlled trials. British Journal of Obstetrics and Gynaecology 1988;95:211-222
20. King JF, Flenady VJ, Papatsonis DNM, Dekker GA, Carbonne B. Calcium channel blockers for inhibiting preterm labour. Cochrane Database of Systematic Reviews 2003, Issue 1. [DOI: 10.1002/14651858.CD002255]
21. King J, Flenady V, Cole S, Thornton S. Cyclo-oxygenase (COX) inhibitors for treating preterm labour. Cochrane Database of Systematic Reviews 2005, Issue 2. [DOI: 10.1002/14651858.CD001992.pub2]
22. Kramer MS. The epidemiology of adverse pregnancy outcomes: an overview. Journal of Nutrition 2003;133:1592S-1596S.
23. Lumley J. Epidemiology of preterm birth. Bailliere's Clinical Obstetrics and Gynaecology 1993;7:477-498
24. Lumley J. Defining the problem: the epidemiology of preterm birth. BJOG: an international journal of obstetrics and gynaecology 2003; 110:3-7.
25. McCain GC, Deatrick JA. The experience of high-risk pregnancy. Journal of Obstetric, Gynecologic and Neonatal Nursing 1993;23:421-427
26. Nanda K, Cook LA, Gallo MF, Grimes DA. Terbutaline pumpmaintenance therapy after threatened pretermlabor for preventing preterm birth. Cochrane Database of Systematic Reviews 2002, Issue 4. [DOI: 10.1002/14651858.CD003933]
27. Papatsonis D, Flenady V, Cole S, Liley H. Oxytocin receptor antagonists for inhibiting preterm labour. Cochrane Database of Systematic Reviews 2005, Issue 3. [DOI: DOI: 10.1002/14651858.CD004452.pub2]
28. Petrou S. Economic consequences of preterm birth and low birthweight. BJOG: an international journal of obstetrics and gynaecology 2003;110 Suppl 20:17-23.
29. Petrou S. The economic consequences of preterm birth during the first 10 years of life. BJOG: an international journal of obstetrics and gynaecology 2005;112(Suppl 1):10-15
30. Powell SL, Holt VL, Hickok DE, Easterling T, Connell FA. Recent changes in delivery site of low-birth-weight infants in Washington: impact on birth weight-specific mortality. American Journal of Obstetrics and Gynecology 1995;173:1585-1592
31. The Cochrane Collaboration. Review Manager (RevMan). 5.0. Copehagan: The Nordic Cochrane Centre: The Cochrane Collaboration, 2008.
32. Sanchez-Ramos L, Valenzuela G, Romero R, Silver H, Koltun W, Millar L, Wang J, Creasy G, Antocin PTL 098 Study Group. A double-blind placebo-controlled trial of oxytocin receptor antagonist (antocin) maintenance therapy in patients with preterm labor. American Journal of Obstetrics and Gynecology 1997;176(1 Pt 2):S30.
33. World Health Organization. Recommended definitions, terminology and format for statistical tables related to the perinatal period and use of a new certificate for cause of perinatal deaths. Acta Obstetricia et Gynecologica Scandinavica 1977;56:247-253